No clearance yet for India’s homegrown Covaxin jab, as WHO seeks ‘additional clarifications’
WHO’s technical advisory group will reconvene next week for a final risk-benefit assessment
WHO’s technical advisory group will reconvene next week for a final risk-benefit assessment